Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Gynecologic 1

Conditions

Platinum-resistant Ovarian Cancer 1

Interventions

Paclitaxel 79 Cisplatin 72 Carboplatin 72 Bevacizumab 29 Radiotherapy 27 Brachytherapy 23 Hyperthermic Intraperitoneal Chemotherapy 20 Drug Therapy 20 olaparib 19 Gemcitabine 17 niraparib 16 apatinib 16 pembrolizumab 15 Surgical Procedures, Operative 15 liposomal doxorubicin 12 Cyclophosphamide 12 Surveys and Questionnaires 11 camrelizumab 10 Taxes 10 Neoadjuvant Therapy 10 fludarabine 9 anlotinib 9 Etoposide 9 Blood Specimen Collection 9 Topotecan 8 Docetaxel 8 Sentinel Lymph Node Biopsy 7 Platinum 7 Injections 7 Cytoreduction Surgical Procedures 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × PHI-101 × Gynecologic × Clear all

NCT04678102 2023-06-26

CREATIVE

Seoul National University Hospital

Phase 1 Unknown

Platinum-resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡